FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Max Lafontan

Research Profile

Physiology

Lipolysis

Anatomy

Chemicals & Drugs

Disorders

Obesity

Co-author Network

Publications

TOP 3
Cedric Moro; Max Lafontan
Natriuretic peptides and cGMP signaling control of energy homeostasis.
Dylan Thompson; Fredrik Karpe; Max Lafontan; Keith Frayn
Physical activity and exercise in the regulation of human adipose tissue physiology.
Max Lafontan
[Kidney, adipose tissue, adipocytes--what's new?].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Max Lafontan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Cedric Moro; Max Lafontan
Natriuretic peptides and cGMP signaling control of energy homeostasis.
American journal of physiology. Heart and circulatory physiology 2013;304(3):H358-68.
2012: Dylan Thompson; Fredrik Karpe; Max Lafontan; Keith Frayn
Physical activity and exercise in the regulation of human adipose tissue physiology.
Physiological reviews 2012;92(1):157-91.
2011: Max Lafontan
[Kidney, adipose tissue, adipocytes--what's new?].
Néphrologie & thérapeutique 2011;7(2):69-79.
2011: Marie-Adeline Marques; Marion Combes; Balbine Roussel; Laurence Vidal-Dupont; Claire Thalamas; Max Lafontan; Nathalie Viguerie
Impact of a mechanical massage on gene expression profile and lipid mobilization in female gluteofemoral adipose tissue.
Obesity facts 2011;4(2):121-9.
2010: Aurélie Villaret; Jean Galitzky; Pauline Decaunes; David Estève; Marie-Adeline Marques; Coralie Sengenes; Patrick Chiotasso; Tamara Tchkonia; Max Lafontan; James L Kirkland; Anne Bouloumié
Adipose tissue endothelial cells from obese human subjects: differences among depots in angiogenic, metabolic, and inflammatory gene expression and cellular senescence.
Diabetes 2010;59(11):2755-63.
2010: Katrien Koppo; Dominique Larrouy; Marie A Marques; Michel Berlan; Magda Bajzova; Jan Polak; Johan Van de Voorde; Jens Bülow; Max Lafontan; François Crampes; Dominique Langin; Vladimir Stich; Isabelle De Glisezinski
Lipid mobilization in subcutaneous adipose tissue during exercise in lean and obese humans. Roles of insulin and natriuretic peptides.
American journal of physiology. Endocrinology and metabolism 2010;299(2):E258-65.
2010: S Wiesner; Andreas L Birkenfeld; Stefan Engeli; S Haufe; L Brechtel; J Wein; M Hermsdorf; B Karnahl; Michel Berlan; Max Lafontan; F C G J Sweep; Friedrich C Luft; Jens Jordan
Neurohumoral and metabolic response to exercise in water.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2010;42(5):334-9.
2009: Carine Duffaut; Alexia Zakaroff-Girard; Virginie Bourlier; Pauline Decaunes; Marie Maumus; Patrick Chiotasso; Coralie Sengenes; Max Lafontan; Jean Galitzky; Anne Bouloumié
Interplay between human adipocytes and T lymphocytes in obesity: CCL20 as an adipochemokine and T lymphocytes as lipogenic modulators.
Arteriosclerosis, thrombosis, and vascular biology 2009;29(10):1608-14.
2009: Max Lafontan; Dominique Langin
Lipolysis and lipid mobilization in human adipose tissue.
Progress in lipid research 2009;48(5):275-97.
2009: Carine Duffaut; Jean Galitzky; Max Lafontan; Anne Bouloumié
Unexpected trafficking of immune cells within the adipose tissue during the onset of obesity.
Biochemical and biophysical research communications 2009;384(4):482-5.
2009: Isabelle De Glisezinski; Dominique Larrouy; Magda Bajzova; K Koppo; Jan Polak; Michel Berlan; J Bulow; Dominique Langin; Marie-Adeline Marques; François Crampes; Max Lafontan; Vladimir Stich
Adrenaline but not noradrenaline is a determinant of exercise-induced lipid mobilization in human subcutaneous adipose tissue.
The Journal of physiology 2009;587(Pt 13):3393-404.
2008: Andreas L Birkenfeld; Petra Budziarek; Michael Boschmann; Cedric Moro; Frauke Adams; Gabriele Franke; Michel Berlan; Marie A Marques; Fred C G J Sweep; Friedrich C Luft; Max Lafontan; Jens Jordan
Atrial natriuretic peptide induces postprandial lipid oxidation in humans.
Diabetes 2008;57(12):3199-204.
2008: Marie Maumus; Coralie Sengenes; Pauline Decaunes; Alexia Zakaroff-Girard; Virginie Bourlier; Max Lafontan; Jean Galitzky; Anne Bouloumié
Evidence of in situ proliferation of adult adipose tissue-derived progenitor cells: influence of fat mass microenvironment and growth.
The Journal of clinical endocrinology and metabolism 2008;93(10):4098-106.
2008: Max Lafontan; J Girard
Impact of visceral adipose tissue on liver metabolism. Part I: heterogeneity of adipose tissue and functional properties of visceral adipose tissue.
Diabetes & metabolism 2008;34(4 Pt 1):317-27.
2008: Cédric Moro; Fabien Pillard; Isabelle De Glisezinski; Eva Klimcakova; Francois Crampes; Claire Thalamas; Isabelle Harant; Marie-Adeline Marques; Max Lafontan; Michel Berlan
Exercise-induced lipid mobilization in subcutaneous adipose tissue is mainly related to natriuretic peptides in overweight men.
American journal of physiology. Endocrinology and metabolism 2008;295(2):E505-13.
2008: Max Lafontan; Cédric Moro; Michel Berlan; François Crampes; Coralie Sengenes; Jean Galitzky
Control of lipolysis by natriuretic peptides and cyclic GMP.
Trends in endocrinology and metabolism: TEM 2008;19(4):130-7.
2008: V Bourlier; Alexia Zakaroff-Girard; Alexandra Miranville; Sandra De Barros; M Maumus; Coralie Sengenes; Jean Galitzky; Max Lafontan; F Karpe; K N Frayn; Anne Bouloumié
Remodeling phenotype of human subcutaneous adipose tissue macrophages.
Circulation 2008;117(6):806-15.
2007: Cédric Moro; Eva Klimcakova; Max Lafontan; Michel Berlan; Jean Galitzky
Phosphodiesterase-5A and neutral endopeptidase activities in human adipocytes do not control atrial natriuretic peptide-mediated lipolysis.
British journal of pharmacology 2007;152(7):1102-10.
2007: Jan Polak; Cédric Moro; David Bessière; Jindra Hejnova; Marie A Marquès; Magda Bajzova; Max Lafontan; François Crampes; Michel Berlan; Vladimir Stich
Acute exposure to long-chain fatty acids impairs {alpha}2-adrenergic receptor-mediated antilipolysis in human adipose tissue.
Journal of lipid research 2007;48(10):2236-46.
2007: Fabien Pillard; Cédric Moro; Isabelle Harant; Eric Garrigue; Max Lafontan; Michel Berlan; François Crampes; Isabelle De Glisezinski; Daniel Rivière
Lipid oxidation according to intensity and exercise duration in overweight men and women.
Obesity (Silver Spring, Md.) 2007;15(9):2256-62.
2007: Cédric Moro; Fabien Pillard; Isabelle De Glisezinski; François Crampes; Claire Thalamas; Isabelle Harant; Marie-Adeline Marques; Max Lafontan; Michel Berlan
Sex differences in lipolysis-regulating mechanisms in overweight subjects: effect of exercise intensity.
Obesity (Silver Spring, Md.) 2007;15(9):2245-55.
2007: Cédric Moro; Fabien Pillard; Isabelle De Glisezinski; François Crampes; Claire Thalamas; Isabelle Harant; Marie-Adeline Marques; Max Lafontan; Michel Berlan
Atrial natriuretic peptide contribution to lipid mobilization and utilization during head-down bed rest in humans.
American journal of physiology. Regulatory, integrative and comparative physiology 2007;293(2):R612-7.
2007: Cédric Moro; Eva Klimcakova; Karine Lolmède; Michel Berlan; Max Lafontan; Vladimir Stich; Anne Bouloumié; Jean Galitzky; Peter Arner; Dominique Langin
Atrial natriuretic peptide inhibits the production of adipokines and cytokines linked to inflammation and insulin resistance in human subcutaneous adipose tissue.
Diabetologia 2007;50(5):1038-47.
2007: Sandra De Barros; Alexia Zakaroff-Girard; Max Lafontan; Jean Galitzky; Virginie Bourlier
Inhibition of human preadipocyte proteasomal activity by HIV protease inhibitors or specific inhibitor lactacystin leads to a defect in adipogenesis, which involves matrix metalloproteinase-9.
The Journal of pharmacology and experimental therapeutics 2007;320(1):291-9.
2006: Andreas L Birkenfeld; Michael Boschmann; Cedric Moro; Frauke Adams; Karsten Heusser; Jens Tank; André Diedrich; Christoph Schroeder; Gabriele Franke; Michel Berlan; Friedrich C Luft; Max Lafontan; Jens Jordan
Beta-adrenergic and atrial natriuretic peptide interactions on human cardiovascular and metabolic regulation.
The Journal of clinical endocrinology and metabolism 2006;91(12):5069-75.
2006: Max Lafontan; Nathalie Viguerie
Role of adipokines in the control of energy metabolism: focus on adiponectin.
Current opinion in pharmacology 2006;6(6):580-5.
2006: Cédric Moro; Jan Polak; Jindra Hejnova; Eva Klimcakova; François Crampes; Vladimir Stich; Max Lafontan; Michel Berlan
Atrial natriuretic peptide stimulates lipid mobilization during repeated bouts of endurance exercise.
American journal of physiology. Endocrinology and metabolism 2006;290(5):E864-9.
2006: Cédric Moro; Michel Berlan; Max Lafontan
[Physiological and pathophysiological features of the control of lipolysis and lipid mobilization by natriuretic peptides].
Journal de la Société de biologie 2006;200(1):67-76.
2005: Coralie Sengenes; Cédric Moro; Jean Galitzky; Michel Berlan; Max Lafontan
[Natriuretic peptides: a new lipolytic pathway in human fat cells].
Médecine sciences : M/S 2005;21 Spec No():29-33.
2005: Jan Polak; Cédric Moro; Eva Klimcakova; Jindra Hejnova; Marek Majercik; Nathalie Viguerie; Dominique Langin; Max Lafontan; Vladimir Stich; Michel Berlan
Dynamic strength training improves insulin sensitivity and functional balance between adrenergic alpha 2A and beta pathways in subcutaneous adipose tissue of obese subjects.
Diabetologia 2005;48(12):2631-40.
2005: Max Lafontan; Cédric Moro; Coralie Sengenes; Jean Galitzky; François Crampes; Michel Berlan
An unsuspected metabolic role for atrial natriuretic peptides: the control of lipolysis, lipid mobilization, and systemic nonesterified fatty acids levels in humans.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(10):2032-42.
2005: Geneviève Tavernier; Maria Jimenez; Jean-Paul Giacobino; Nicolas Hulo; Max Lafontan; Patrick Muzzin; Dominique Langin
Norepinephrine induces lipolysis in beta1/beta2/beta3-adrenoceptor knockout mice.
Molecular pharmacology 2005;68(3):793-9.
2005: Cédric Moro; Fabien Pillard; Isabelle De Glisezinski; Isabelle Harant; Daniel Rivière; Vladimir Stich; Max Lafontan; François Crampes; Michel Berlan
Training enhances ANP lipid-mobilizing action in adipose tissue of overweight men.
Medicine and science in sports and exercise 2005;37(7):1126-32.
2005: Andreas L Birkenfeld; Michael Boschmann; Cedric Moro; Frauke Adams; Karsten Heusser; Gabriele Franke; Michel Berlan; Friedrich C Luft; Max Lafontan; Jens Jordan
Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans.
The Journal of clinical endocrinology and metabolism 2005;90(6):3622-8.
2005: Virginie Bourlier; Alexia Zakaroff-Girard; Sandra De Barros; Christophe Pizzacalla; Véronique Durand de Saint Front; Max Lafontan; Anne Bouloumié; Jean Galitzky
Protease inhibitor treatments reveal specific involvement of matrix metalloproteinase-9 in human adipocyte differentiation.
The Journal of pharmacology and experimental therapeutics 2005;312(3):1272-9.
2005: Max Lafontan
Fat cells: afferent and efferent messages define new approaches to treat obesity.
Annual review of pharmacology and toxicology 2005;45():119-46.
2005: Coralie Sengenes; Cédric Moro; Jean Galitzky; Michel Berlan; Max Lafontan
[Natriuretic peptides: a new lipolytic pathway in human fat cells].
Médecine sciences : M/S 2005;21(1):61-5.
2005: Cédric Moro; Jan Polak; Blanka Richterova; Coralie Sengenes; Terezie Pelikanova; Jean Galitzky; Vladimir Stich; Max Lafontan; Michel Berlan
Differential regulation of atrial natriuretic peptide- and adrenergic receptor-dependent lipolytic pathways in human adipose tissue.
Metabolism: clinical and experimental 2005;54(1):122-31.
2004: Cédric Moro; François Crampes; Coralie Sengenes; Isabelle De Glisezinski; Jean Galitzky; Claire Thalamas; Max Lafontan; Michel Berlan
Atrial natriuretic peptide contributes to physiological control of lipid mobilization in humans.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2004;18(7):908-10.
2004: Blanka Richterova; Vladimir Stich; Cédric Moro; Jan Polak; Eva Klimcakova; Marek Majercik; Isabelle Harant; Nathalie Viguerie; François Crampes; Dominique Langin; Max Lafontan; Michel Berlan
Effect of endurance training on adrenergic control of lipolysis in adipose tissue of obese women.
The Journal of clinical endocrinology and metabolism 2004;89(3):1325-31.
2004: Cédric Moro; Jean Galitzky; Coralie Sengenes; François Crampes; Max Lafontan; Michel Berlan
Functional and pharmacological characterization of the natriuretic peptide-dependent lipolytic pathway in human fat cells.
The Journal of pharmacology and experimental therapeutics 2004;308(3):984-92.
2003: Coralie Sengenes; Anne Bouloumie; Hans Hauner; Michel Berlan; Rudi Busse; Max Lafontan; Jean Galitzky
Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes.
The Journal of biological chemistry 2003;278(49):48617-26.
2003: Karine Lolmède; V Durand de Saint Front; Jean Galitzky; Max Lafontan; Anne Bouloumié
Effects of hypoxia on the expression of proangiogenic factors in differentiated 3T3-F442A adipocytes.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2003;27(10):1187-95.
2003: Vladimir Stich; Terezie Pelikanova; Petr Wohl; Coralie Sengenes; Alexia Zakaroff-Girard; Max Lafontan; Michel Berlan
Activation of alpha2-adrenergic receptors blunts epinephrine-induced lipolysis in subcutaneous adipose tissue during a hyperinsulinemic euglycemic clamp in men.
American journal of physiology. Endocrinology and metabolism 2003;285(3):E599-607.
2003: Christelle Mérial-Kieny; Michel Lonchampt; Francis Cogé; Patrick Verwaerde; Jean-Pierre Galizzi; Jean A Boutin; Max Lafontan; Nigel Levens; Jean Galitzky; Michel Félétou
Endothelin-1 inhibits TNF alpha-induced iNOS expression in 3T3-F442A adipocytes.
British journal of pharmacology 2003;139(5):935-44.
2003: Max Lafontan; Michel Berlan
Do regional differences in adipocyte biology provide new pathophysiological insights?
Trends in pharmacological sciences 2003;24(6):276-83.
2003: Stephane Gesta; Karine Lolmède; Danièle Daviaud; Michel Berlan; Anne Bouloumié; Max Lafontan; Philippe Valet; Jean Sébastien Saulnier-Blache
Culture of human adipose tissue explants leads to profound alteration of adipocyte gene expression.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2003;35(3):158-63.
2003: Fabrice Marion-Latard; François Crampes; Alexia Zakaroff-Girard; Isabelle De Glisezinski; Isabelle Harant; Vladimir Stich; Claire Thalamas; Daniel Rivière; Max Lafontan; Michel Berlan
Post-exercise increase of lipid oxidation after a moderate exercise bout in untrained healthy obese men.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2003;35(2):97-103.
2003: François Crampes; Fabrice Marion-Latard; Alexia Zakaroff-Girard; Isabelle De Glisezinski; Isabelle Harant; Claire Thalamas; Vladimir Stich; Daniel Rivière; Max Lafontan; Michel Berlan
Effects of a longitudinal training program on responses to exercise in overweight men.
Obesity research 2003;11(2):247-56.
2003: Michel Pelat; Patrick Verwaerde; Jean Galitzky; Max Lafontan; Michel Berlan; Jean-Michel Senard; Jean-Louis Montastruc
High isoproterenol doses are required to activate beta3-adrenoceptor-mediated functions in dogs.
The Journal of pharmacology and experimental therapeutics 2003;304(1):246-53.
2002: Jeremie Boucher; Isabelle Castan-Laurell; Soazig Le Lay; D Grujic; David Sibrac; Stéphane Krief; Max Lafontan; Bradford B Lowell; Isabelle Dugail; Jean Sébastien Saulnier-Blache; Philippe Valet
Human alpha 2A-adrenergic receptor gene expressed in transgenic mouse adipose tissue under the control of its regulatory elements.
Journal of molecular endocrinology 2002;29(2):251-64.
2002: Michel Berlan; Stephan Verhaeghe; Anne Pavy-Le Traon; Claire Thalamas; Max Lafontan; Marie-Adeline Marques; Jean-Michel Senard; Marc Parent; Jean Galitzky
Yohimbine administration prevents over-responsiveness to epinephrine induced by simulated microgravity.
Aviation, space, and environmental medicine 2002;73(8):735-42.
2002: Coralie Sengenes; Alexia Zakaroff-Girard; Agnès Moulin; Michel Berlan; Anne Bouloumié; Max Lafontan; Jean Galitzky
Natriuretic peptide-dependent lipolysis in fat cells is a primate specificity.
American journal of physiology. Regulatory, integrative and comparative physiology 2002;283(1):R257-65.
2002: Stephane Gesta; Marie-Françoise Simon; Astrid Rey; David Sibrac; Alexia Girard; Max Lafontan; Philippe Valet; Jean Sébastien Saulnier-Blache
Secretion of a lysophospholipase D activity by adipocytes: involvement in lysophosphatidic acid synthesis.
Journal of lipid research 2002;43(6):904-10.
2002: Anne Bouloumié; Karine Lolmède; Coralie Sengenes; Jean Galitzky; Max Lafontan
Angiogenesis in adipose tissue.
Annales d'endocrinologie 2002;63(2 Pt 1):91-5.
2002: Max Lafontan; Michel Berlan; Vladimir Stich; François Crampes; Daniel Rivière; Isabelle De Glisezinski; Coralie Sengenes; Jean Galitzky
Recent data on the regulation of lipolysis by catecholamines and natriuretic peptides.
Annales d'endocrinologie 2002;63(2 Pt 1):86-90.
2002: Vladimir Stich; Fabrice Marion-Latard; Jindra Hejnova; Nathalie Viguerie; Corinne Lefort; Hana Suljkovicova; Dominique Langin; Max Lafontan; Michel Berlan
Hypocaloric diet reduces exercise-induced alpha 2-adrenergic antilipolytic effect and alpha 2-adrenergic receptor mRNA levels in adipose tissue of obese women.
The Journal of clinical endocrinology and metabolism 2002;87(3):1274-81.
2002: Isabelle Castan-Laurell; Jeremie Boucher; Astrid Rey; David Sibrac; Stephane Gesta; C Pagès; Danièle Daviaud; Marie-Françoise Simon; Max Lafontan; J S Saulnier-Blachet; Philippe Valet
[Development of nutritional obesity in transgenic mice with an adrenergic receptivity in adipose tissue comparable with that of humans].
Pathologie-biologie 2002;50(1):52-7.
2002: Fatima Smih; Philippe ROUET; Stéphanie Lucas; Aline Mairal; Coralie Sengenes; Max Lafontan; Sophie Vaulont; Marta Casado; Dominique Langin
Transcriptional regulation of adipocyte hormone-sensitive lipase by glucose.
Diabetes 2002;51(2):293-300.
2002: Coralie Sengenes; Vladimir Stich; Michel Berlan; Jindra Hejnova; Max Lafontan; Z Pariskova; Jean Galitzky
Increased lipolysis in adipose tissue and lipid mobilization to natriuretic peptides during low-calorie diet in obese women.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2002;26(1):24-32.
2001: Max Lafontan
[Lipid metabolism in adipose tissue: adrenergic control of the adipocyte and mobilization if the lipids].
Annales d'endocrinologie 2001;62(4 Pt 2):S7-17.
2001: Anne Bouloumié; Coralie Sengenes; G Portolan; Jean Galitzky; Max Lafontan
Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation.
Diabetes 2001;50(9):2080-6.
2001: C Pages; Danièle Daviaud; S An; Stéphane Krief; Max Lafontan; Philippe Valet; Jean Sébastien Saulnier-Blache
Endothelial differentiation gene-2 receptor is involved in lysophosphatidic acid-dependent control of 3T3F442A preadipocyte proliferation and spreading.
The Journal of biological chemistry 2001;276(15):11599-605.
2001: Christian Carpéné; Nathalie Morin; Emi Fontana; Virgile Visentin; Danielle Prévot; Luc Marti; Max Lafontan
Histamine weakly stimulates lipolysis and is poorly oxidized by amine oxidases in human subcutaneous fat cells.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2001;50 Suppl 2():S140-1.
2001: Jean Galitzky; Coralie Sengenes; Claire Thalamas; Marie-Adeline Marques; J M Senard; Max Lafontan; Michel Berlan
The lipid-mobilizing effect of atrial natriuretic peptide is unrelated to sympathetic nervous system activation or obesity in young men.
Journal of lipid research 2001;42(4):536-44.
2000: Max Lafontan; Michel Berlan; Jean Galitzky
[Lipid mobilization and energy metabolism: impact of molecular and cellular approaches on the treatment of obesity].
Annales d'endocrinologie 2000;61 Suppl 6():56-69.
2000: Jean Sébastien Saulnier-Blache; Alexia Girard; Marie-Françoise Simon; Max Lafontan; Philippe Valet
A simple and highly sensitive radioenzymatic assay for lysophosphatidic acid quantification.
Journal of lipid research 2000;41(12):1947-51.
2000: Philippe Valet; D Grujic; J Wade; M Ito; Maria Cristina Zingaretti; V Soloveva; S R Ross; R A Graves; Saverio Cinti; Max Lafontan; Bradford B Lowell
Expression of human alpha 2-adrenergic receptors in adipose tissue of beta 3-adrenergic receptor-deficient mice promotes diet-induced obesity.
The Journal of biological chemistry 2000;275(44):34797-802.
2000: Dominique Langin; Stéphanie Lucas; Max Lafontan
Millennium fat-cell lipolysis reveals unsuspected novel tracks.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2000;32(11-12):443-52.
2000: Max Lafontan; Coralie Sengenes; Jean Galitzky; Michel Berlan; Isabelle De Glisezinski; François Crampes; Vladimir Stich; Dominique Langin; Pierre Barbe; Daniel Rivière
Recent developments on lipolysis regulation in humans and discovery of a new lipolytic pathway.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2000;24 Suppl 4():S47-52.
2000: C Merial; Anne Bouloumie; V Trocheris; Max Lafontan; Jean Galitzky
Nitric oxide-dependent downregulation of adipocyte UCP-2 expression by tumor necrosis factor-alpha.
American journal of physiology. Cell physiology 2000;279(4):C1100-6.
2000: Vladimir Stich; Isabelle De Glisezinski; François Crampes; Jindra Hejnova; JM Cottet-Emard; Jean Galitzky; Max Lafontan; Daniel Rivière; Michel Berlan
Activation of alpha(2)-adrenergic receptors impairs exercise-induced lipolysis in SCAT of obese subjects.
American journal of physiology. Regulatory, integrative and comparative physiology 2000;279(2):R499-504.
2000: Coralie Sengenes; Michel Berlan; Isabelle De Glisezinski; Max Lafontan; Jean Galitzky
Natriuretic peptides: a new lipolytic pathway in human adipocytes.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2000;14(10):1345-51.
2000: Claire Thalamas; Jean Galitzky; Jean-Michel Sénard; Max Lafontan; Jean-Louis Montastruc; Michel Berlan; Pierre Barbe
Glucose-induced sympathetic activity and energy expenditure during acute alpha2-adrenergic antagonism in obese subjects.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2000;24(6):695-700.
2000: G Pagès; Alexia Girard; O Jeanneton; Pierre Barbe; C Wolf; Max Lafontan; Philippe Valet; Jean Sébastien Saulnier-Blache
LPA as a paracrine mediator of adipocyte growth and function.
Annals of the New York Academy of Sciences 2000;905():159-64.
2000: Vladimir Stich; Isabelle De Glisezinski; Michel Berlan; J Bulow; Jean Galitzky; Isabelle Harant; Hana Suljkovicova; Max Lafontan; Daniel Rivière; François Crampes
Adipose tissue lipolysis is increased during a repeated bout of aerobic exercise.
Journal of applied physiology (Bethesda, Md. : 1985) 2000;88(4):1277-83.
1999: Nathalie Pizzinat; Luc Marti; A Remaury; F Leger; Dominique Langin; Max Lafontan; Christian Carpéné; angelo parini
High expression of monoamine oxidases in human white adipose tissue: evidence for their involvement in noradrenaline clearance.
Biochemical pharmacology 1999;58(11):1735-42.
1999: C Pagès; Astrid Rey; Max Lafontan; Philippe Valet; Jean Sébastien Saulnier-Blache
Ca(2+)-independent phospholipase A2 is required for alpha2-adrenergic-induced preadipocyte spreading.
Biochemical and biophysical research communications 1999;265(2):572-6.
1999: Pierre Barbe; Jean Galitzky; Claire Thalamas; Dominique Langin; Max Lafontan; Jean-Michel Senard; Michel Berlan
Increase in epinephrine-induced responsiveness during microgravity simulated by head-down bed rest in humans.
Journal of applied physiology (Bethesda, Md. : 1985) 1999;87(5):1614-20.
1999: Vladimir Stich; Isabelle De Glisezinski; François Crampes; Hana Suljkovicova; Jean Galitzky; Daniel Riviere; Jindra Hejnova; Max Lafontan; Michel Berlan
Activation of antilipolytic alpha(2)-adrenergic receptors by epinephrine during exercise in human adipose tissue.
The American journal of physiology 1999;277(4 Pt 2):R1076-83.
1999: Patrick Verwaerde; Jean-Michel Sénard; Michel Galinier; P Rougé; Pierre Massabuau; Jean Galitzky; Michel Berlan; Max Lafontan; Jean-Louis Montastruc
Changes in short-term variability of blood pressure and heart rate during the development of obesity-associated hypertension in high-fat fed dogs.
Journal of hypertension 1999;17(8):1135-43.
1999: Anne Bouloumie; T Marumo; Max Lafontan; Rudi Busse
Leptin induces oxidative stress in human endothelial cells.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1999;13(10):1231-8.
1999: Christian Carpéné; Jean Galitzky; Emi Fontana; C Atgié; Max Lafontan; Michel Berlan
Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells.
Naunyn-Schmiedeberg's archives of pharmacology 1999;359(4):310-21.
1999: A Bousquet-Mélou; C Muñoz; Jean Galitzky; Michel Berlan; Max Lafontan
Pregnancy modifies the alpha2-beta-adrenergic receptor functional balance in rabbit fat cells.
Journal of lipid research 1999;40(2):267-74.
1999: C Pagès; Philippe Valet; O Jeanneton; Alexia Zakaroff-Girard; Pierre Barbe; M Record; C Wolf; F Chevy; Max Lafontan; Jean Sébastien Saulnier-Blache
Alpha2-adrenergic receptor-mediated release of lysophosphatidic acid by adipocytes: a paracrine signal for preadipocyte growth.
Lipids 1999;34 Suppl():S79.
1999: Jean-Louis Montastruc; Patrick Verwaerde; Michel Pelat; Jean Galitzky; Dominique Langin; Max Lafontan; Michel Berlan
Peripheral cardiovascular actions of SR 58611 A, a beta 3-adrenoceptor agonist, in the dog: lack of central effect.
Fundamental & clinical pharmacology 1999;13(2):180-6.
1998: Anne Bouloumié; H C Drexler; Max Lafontan; Rudi Busse
Leptin, the product of Ob gene, promotes angiogenesis.
Circulation research 1998;83(10):1059-66.
1998: Laurence Millet; Pierre Barbe; Max Lafontan; Michel Berlan; Jean Galitzky
Catecholamine effects on lipolysis and blood flow in human abdominal and femoral adipose tissue.
Journal of applied physiology (Bethesda, Md. : 1985) 1998;85(1):181-8.
1998: S Bétuing; Danièle Daviaud; C Pagès; E Bonnard; Philippe Valet; Max Lafontan; Jean Sébastien Saulnier-Blache
Gbeta gamma-independent coupling of alpha2-adrenergic receptor to p21(rhoA) in preadipocytes.
The Journal of biological chemistry 1998;273(25):15804-10.
1998: Luc Marti; Nathalie Morin; G Enrique-Tarancon; D Prevot; Max Lafontan; Xavier Testar; Antonio Zorzano; Christian Carpéné
Tyramine and vanadate synergistically stimulate glucose transport in rat adipocytes by amine oxidase-dependent generation of hydrogen peroxide.
The Journal of pharmacology and experimental therapeutics 1998;285(1):342-9.
1998: Philippe Valet; C Pagès; O Jeanneton; Danièle Daviaud; Pierre Barbe; M Record; Jean Sébastien Saulnier-Blache; Max Lafontan
Alpha2-adrenergic receptor-mediated release of lysophosphatidic acid by adipocytes. A paracrine signal for preadipocyte growth.
The Journal of clinical investigation 1998;101(7):1431-8.
1998: Pierre Barbe; Jean Galitzky; Isabelle De Glisezinski; Daniel Riviere; Claire Thalamas; Jean-Michel Senard; François Crampes; Max Lafontan; Michel Berlan
Simulated microgravity increases beta-adrenergic lipolysis in human adipose tissue.
The Journal of clinical endocrinology and metabolism 1998;83(2):619-25.
1998: Max Lafontan; S Betuing; Jean Sébastien Saulnier-Blache; Philippe Valet; Anne Bouloumié; Christian Carpéné; Jean Galitzky; Michel Berlan
Regulation of fat-cell function by alpha 2-adrenergic receptors.
Advances in pharmacology (San Diego, Calif.) 1998;42():496-8.
1997: Jean Galitzky; Dominique Langin; Patrick Verwaerde; Jean-Louis Montastruc; Max Lafontan; Michel Berlan
Lipolytic effects of conventional beta 3-adrenoceptor agonists and of CGP 12,177 in rat and human fat cells: preliminary pharmacological evidence for a putative beta 4-adrenoceptor.
British journal of pharmacology 1997;122(6):1244-50.
1997: Max Lafontan; Pierre Barbe; Jean Galitzky; Geneviève Tavernier; Dominique Langin; Christian Carpéné; A Bousquet-Melou; Michel Berlan
Adrenergic regulation of adipocyte metabolism.
Human reproduction (Oxford, England) 1997;12 Suppl 1():6-20.
1997: S Bétuing; Philippe Valet; S Lapalu; D Peyroulan; G Hickson; Danièle Daviaud; Max Lafontan; Jean Sébastien Saulnier-Blache
Functional consequences of constitutively active alpha2A-adrenergic receptor expression in 3T3F442A preadipocytes and adipocytes.
Biochemical and biophysical research communications 1997;235(3):765-73.
1997: Thierry Raclot; Dominique Langin; Max Lafontan; René Groscolas
Selective release of human adipocyte fatty acids according to molecular structure.
The Biochemical journal 1997;324 ( Pt 3)():911-5.
1997: Vladimir Stich; Isabelle Harant; Isabelle De Glisezinski; François Crampes; Michel Berlan; Marie Kunesova; Vojtech Hainer; M Dauzats; Daniel Rivière; M Garrigues; Cecilia Holm; Max Lafontan; Dominique Langin
Adipose tissue lipolysis and hormone-sensitive lipase expression during very-low-calorie diet in obese female identical twins.
The Journal of clinical endocrinology and metabolism 1997;82(3):739-44.
1997: Pierre Barbe; Vladimir Stich; Jean Galitzky; Marie Kunesova; Vojtech Hainer; Max Lafontan; Michel Berlan
In vivo increase in beta-adrenergic lipolytic response in subcutaneous adipose tissue of obese subjects submitted to a hypocaloric diet.
The Journal of clinical endocrinology and metabolism 1997;82(1):63-9.
1996: C Atgié; Geneviève Tavernier; F D'Allaire; T Bengtsson; Luc Marti; Christian Carpéné; Max Lafontan; Ludwik J Bukowiecki; Dominique Langin
Beta 3-adrenoceptor in guinea pig brown and white adipocytes: low expression and lack of function.
The American journal of physiology 1996;271(6 Pt 2):R1729-38.
1996: S Bétuing; Danièle Daviaud; Philippe Valet; A Bouloumié; Max Lafontan; Jean Sébastien Saulnier-Blache
alpha2-Adrenoceptor stimulation promotes actin polymerization and focal adhesion in 3T3F442A and BFC-1beta preadipocytes.
Endocrinology 1996;137(12):5220-9.
1996: Pierre Barbe; Laurence Millet; Jean Galitzky; Max Lafontan; Michel Berlan
In situ assessment of the role of the beta 1-, beta 2- and beta 3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue.
British journal of pharmacology 1996;117(5):907-13.
1996: Dominique Langin; Cecilia Holm; Max Lafontan
Adipocyte hormone-sensitive lipase: a major regulator of lipid metabolism.
The Proceedings of the Nutrition Society 1996;55(1B):93-109.
1996: Geneviève Tavernier; Pierre Barbe; Jean Galitzky; Michel Berlan; D Caput; Max Lafontan; Dominique Langin
Expression of beta3-adrenoceptors with low lipolytic action in human subcutaneous white adipocytes.
Journal of lipid research 1996;37(1):87-97.
1995: Max Lafontan; Michel Berlan
Fat cell alpha 2-adrenoceptors: the regulation of fat cell function and lipolysis.
Endocrine reviews 1995;16(6):716-38.
1995: Max Lafontan; A Bousquet-Melou; Jean Galitzky; Pierre Barbe; Christian Carpéné; Dominique Langin; Michel Berlan; Philippe Valet; I Castan; A Bouloumié
Adrenergic receptors and fat cells: differential recruitment by physiological amines and homologous regulation.
Obesity research 1995;3 Suppl 4():507S-514S.
1995: Christian Carpéné; Luc Marti; A Hudson; Max Lafontan
Nonadrenergic imidazoline binding sites and amine oxidase activities in fat cells.
Annals of the New York Academy of Sciences 1995;763():380-97.
1995: Geneviève Tavernier; Jean Galitzky; Philippe Valet; A Remaury; A Bouloumie; Max Lafontan; Dominique Langin
Molecular mechanisms underlying regional variations of catecholamine-induced lipolysis in rat adipocytes.
The American journal of physiology 1995;268(6 Pt 1):E1135-42.
1995: A Bousquet-Mélou; Jean Galitzky; C M Moreno; Michel Berlan; Max Lafontan
Desensitization of beta-adrenergic responses in adipocytes involves receptor subtypes and cAMP phosphodiesterase.
European journal of pharmacology 1995;289(2):235-47.
1995: A Bousquet-Mélou; Jean Galitzky; Max Lafontan; Michel Berlan
Control of lipolysis in intra-abdominal fat cells of nonhuman primates: comparison with humans.
Journal of lipid research 1995;36(3):451-61.
1995: Max Lafontan; Dominique Langin
Cellular aspects of fuel mobilization and selection in white adipocytes.
The Proceedings of the Nutrition Society 1995;54(1):49-63.
1995: Christian Carpéné; P Collon; A Remaury; A Cordi; A Hudson; D Nutt; Max Lafontan
Inhibition of amine oxidase activity by derivatives that recognize imidazoline I2 sites.
The Journal of pharmacology and experimental therapeutics 1995;272(2):681-8.
1995: I Castan; J C Devedjian; Philippe Valet; Hervé Paris; Max Lafontan
Human adipocytes express alpha 2-adrenergic receptor of the alpha 2A-subtype only: pharmacological and genetic evidence.
Fundamental & clinical pharmacology 1995;9(6):569-75.
1995: Jean Galitzky; Christian Carpéné; A Bousquet-Mélou; Michel Berlan; Max Lafontan
Differential activation of beta 1-, beta 2- and beta 3-adrenoceptors by catecholamines in white and brown adipocytes.
Fundamental & clinical pharmacology 1995;9(4):324-31.
1995: Michel Berlan; Pierre Barbe; Vladimir Stich; Jean Galitzky; A Bousquet-Mélou; Max Lafontan
[Lipid mobilization, physiopathological and pharmacological aspects].
Annales d'endocrinologie 1995;56(2):97-100.
1995: Dominique Langin; Geneviève Tavernier; Max Lafontan
Regulation of beta 3-adrenoceptor expression in white fat cells.
Fundamental & clinical pharmacology 1995;9(2):97-106.
1994: A Bouloumié; V Planat; J C Devedjian; Philippe Valet; Jean Sébastien Saulnier-Blache; M Record; Max Lafontan
Alpha 2-adrenergic stimulation promotes preadipocyte proliferation. Involvement of mitogen-activated protein kinases.
The Journal of biological chemistry 1994;269(48):30254-9.
1994: A Bouloumie; Philippe Valet; M Dauzats; Max Lafontan; Jean Sébastien Saulnier-Blache
In vivo upregulation of adipocyte alpha 2-adrenoceptors by androgens is consequence of direct action on fat cells.
The American journal of physiology 1994;267(4 Pt 1):C926-31.
1994: A Bouloumié; Philippe Valet; Danièle Daviaud; Hervé Prats; Max Lafontan; Jean Sébastien Saulnier-Blache
Adipocyte alpha 2A-adrenoceptor is the only alpha 2-adrenoceptor regulated by testosterone.
European journal of pharmacology 1994;269(1):95-103.
1994: A Bousquet-Mélou; Jean Galitzky; Christian Carpéné; Max Lafontan; Michel Berlan
beta-Adrenergic control of lipolysis in primate white fat cells: a comparative study with nonprimate mammals.
The American journal of physiology 1994;267(1 Pt 2):R115-23.
1994: Max Lafontan
Differential recruitment and differential regulation by physiological amines of fat cell beta-1, beta-2 and beta-3 adrenergic receptors expressed in native fat cells and in transfected cell lines.
Cellular signalling 1994;6(4):363-92.
1994: Dominique Larrouy; A Remaury; Danièle Daviaud; Max Lafontan
Coupling of inhibitory receptors with Gi-proteins in hamster adipocytes: comparison between adenosine A1 receptor and alpha 2-adrenoceptor.
European journal of pharmacology 1994;267(2):225-32.
1994: I Castan; Philippe Valet; N Quideau; Thierry Voisin; L Ambid; Marc Laburthe; Max Lafontan; Christian Carpéné
Antilipolytic effects of alpha 2-adrenergic agonists, neuropeptide Y, adenosine, and PGE1 in mammal adipocytes.
The American journal of physiology 1994;266(4 Pt 2):R1141-7.
1994: Christian Carpéné; I Castan; P Collon; Jean Galitzky; J Moratinos; Max Lafontan
Adrenergic lipolysis in guinea pig is not a beta 3-adrenergic response: comparison with human adipocytes.
The American journal of physiology 1994;266(3 Pt 2):R905-13.
1994: Christian Carpéné; L Ambid; Max Lafontan
Predominance of beta 3-adrenergic component in catecholamine activation of lipolysis in garden dormouse adipocytes.
The American journal of physiology 1994;266(3 Pt 2):R896-904.
1994: Michel Berlan; Jean Galitzky; A Bousquet-Melou; Max Lafontan; Jean-Louis Montastruc
Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog.
The Journal of pharmacology and experimental therapeutics 1994;268(3):1444-51.
1993: Christian Carpéné; E Chalaux; M Lizarbe; A Estrada; C Mora; M Palacin; Antonio Zorzano; Max Lafontan; Xavier Testar
Beta 3-adrenergic receptors are responsible for the adrenergic inhibition of insulin-stimulated glucose transport in rat adipocytes.
The Biochemical journal 1993;296 ( Pt 1)():99-105.
1993: Béatrice Cousin; Louis Casteilla; Max Lafontan; L Ambid; Dominique Langin; Marie-France Berthault; Luc Pénicaud
Local sympathetic denervation of white adipose tissue in rats induces preadipocyte proliferation without noticeable changes in metabolism.
Endocrinology 1993;133(5):2255-62.
1993: I Castan; Philippe Valet; Dominique Larrouy; Thierry Voisin; A Remaury; Danièle Daviaud; Marc Laburthe; Max Lafontan
Distribution of PYY receptors in human fat cells: an antilipolytic system alongside the alpha 2-adrenergic system.
The American journal of physiology 1993;265(1 Pt 1):E74-80.
1993: Pierre Barbe; Jean Galitzky; Daniel Riviere; Jean-Michel Senard; Max Lafontan; M Garrigues; Michel Berlan
Effects of physiological and pharmacological variation of sympathetic nervous system activity on plasma non-esterified fatty acid concentrations in man.
British journal of clinical pharmacology 1993;36(1):25-30.
1993: Max Lafontan; Michel Berlan
Fat cell adrenergic receptors and the control of white and brown fat cell function.
Journal of lipid research 1993;34(7):1057-91.
1993: Jean Galitzky; M Reverte; C Carpene; Max Lafontan; Michel Berlan
Beta 3-adrenoceptors in dog adipose tissue: studies on their involvement in the lipomobilizing effect of catecholamines.
The Journal of pharmacology and experimental therapeutics 1993;266(1):358-66.
1993: Jean Galitzky; Max Lafontan; J Nordenström; P Arner
Role of vascular alpha-2 adrenoceptors in regulating lipid mobilization from human adipose tissue.
The Journal of clinical investigation 1993;91(5):1997-2003.
1993: Christian Carpéné; Jean Galitzky; P Collon; F Esclapez; M Dauzats; Max Lafontan
Desensitization of beta-1 and beta-2, but not beta-3, adrenoceptor-mediated lipolytic responses of adipocytes after long-term norepinephrine infusion.
The Journal of pharmacology and experimental therapeutics 1993;265(1):237-47.
1993: Jean Galitzky; M Reverte; María P Portillo; Christian Carpéné; Max Lafontan; Michel Berlan
Coexistence of beta 1-, beta 2-, and beta 3-adrenoceptors in dog fat cells and their differential activation by catecholamines.
The American journal of physiology 1993;264(3 Pt 1):E403-12.
1993: Jean Galitzky; C Carpene; Max Lafontan; Michel Berlan
[Specific stimulation of adipose tissue adrenergic beta 3 receptors by octopamine].
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1993;316(5):519-23.
1992: I Castan; Philippe Valet; Thierry Voisin; N Quideau; Marc Laburthe; Max Lafontan
Identification and functional studies of a specific peptide YY-preferring receptor in dog adipocytes.
Endocrinology 1992;131(4):1970-6.
1992: Max Lafontan; Dominique Langin; María P Portillo; Hervé Paris
Imidazoline binding sites in fat cells. Localization and pharmacologic differentiation from alpha 2-adrenergic receptors.
American journal of hypertension 1992;5(4 Pt 2):72S-79S.
1992: Max Lafontan; Michel Berlan; Jean Galitzky; Jean-Louis Montastruc
Alpha-2 adrenoceptors in lipolysis: alpha 2 antagonists and lipid-mobilizing strategies.
The American journal of clinical nutrition 1992;55(1 Suppl):219S-227S.
1992: Jean Sébastien Saulnier-Blache; A Bouloumie; Philippe Valet; J C Devedjian; Max Lafontan
Androgenic regulation of adipocyte alpha 2-adrenoceptor expression in male and female Syrian hamsters: proposed transcriptional mechanism.
Endocrinology 1992;130(1):316-27.
1992: Dominique Langin; María P Portillo; M Dauzats; Max Lafontan
Drop in the "atypical" beta-adrenergic response and modification of the beta/alpha 2-adrenoceptor balance in fat cells from aging rabbits.
Endocrinology 1992;130(1):307-15.
1991: Jean Galitzky; M Vermorel; Max Lafontan; P Montastruc; Michel Berlan
Thermogenic and lipolytic effect of yohimbine in the dog.
British journal of pharmacology 1991;104(2):514-8.
1991: Jean Sébastien Saulnier-Blache; M Dauzats; Danièle Daviaud; D Gaillard; G Ailhaud; R Négrel; Max Lafontan
Late expression of alpha 2-adrenergic-mediated antilipolysis during differentiation of hamster preadipocytes.
Journal of lipid research 1991;32(9):1489-99.
1991: Dominique Langin; María P Portillo; Jean Sébastien Saulnier-Blache; Max Lafontan
Coexistence of three beta-adrenoceptor subtypes in white fat cells of various mammalian species.
European journal of pharmacology 1991;199(3):291-301.
1991: Michel Berlan; Jean Galitzky; Daniel Riviere; M Foureau; Marie-Antoinette Tran; R Flores; J P Louvet; G Houin; Max Lafontan
Plasma catecholamine levels and lipid mobilization induced by yohimbine in obese and non-obese women.
International journal of obesity 1991;15(5):305-15.
1991: Dominique Larrouy; Jean Galitzky; Max Lafontan
A1 adenosine receptors in the human fat cell: tissue distribution and regulation of radioligand binding.
European journal of pharmacology 1991;206(2):139-47.
1990: Jean Sébastien Saulnier-Blache; Dominique Larrouy; Christian Carpéné; N Quideau; M Dauzats; Max Lafontan
Photoperiodic control of adipocyte alpha 2-adrenoceptors in Syrian hamsters: role of testosterone.
Endocrinology 1990;127(3):1245-53.
1990: Jean Galitzky; J M Senard; Max Lafontan; M Stillings; Jean-Louis Montastruc; Michel Berlan
Identification of human platelet alpha 2-adrenoceptors with a new antagonist [3H]-RX821002, a 2-methoxy derivative of idazoxan.
British journal of pharmacology 1990;100(4):862-6.
1990: Christian Carpéné; Jean Galitzky; Dominique Larrouy; Dominique Langin; Max Lafontan
Non-adrenergic sites for imidazolines are not directly involved in the alpha 2-adrenergic antilipolytic effect of UK 14304 in rat adipocytes.
Biochemical pharmacology 1990;40(3):437-45.
1990: Christian Carpéné; Jean Galitzky; Jean Sébastien Saulnier-Blache; Max Lafontan
Selective reduction of alpha 2-adrenergic responsiveness in hamster adipose tissue during prolonged starvation.
The American journal of physiology 1990;259(1 Pt 1):E80-8.
1990: Dominique Langin; Hervé Paris; Max Lafontan
Binding of [3H]idazoxan and of its methoxy derivative [3H] RX821002 in human fat cells: [3H]idazoxan but not [3H] RX821002 labels additional non-alpha 2-adrenergic binding sites.
Molecular pharmacology 1990;37(6):876-85.
1990: Jean Sébastien Saulnier-Blache; C Atgie; C Carpene; N Quideau; Max Lafontan
Hamster adipocyte alpha 2-adrenoceptor changes during fat mass modifications are not directly dependent on adipose tissue norepinephrine content.
Endocrinology 1990;126(5):2425-34.
1990: Dominique Langin; Hervé Paris; M Dauzats; Max Lafontan
Discrimination between alpha 2-adrenoceptors and [3H]idazoxan-labelled non-adrenergic sites in rabbit white fat cells.
European journal of pharmacology 1990;188(4-5):261-72.
1990: Philippe Valet; Michel Berlan; M Beauville; François Crampes; Jean-Louis Montastruc; Max Lafontan
Neuropeptide Y and peptide YY inhibit lipolysis in human and dog fat cells through a pertussis toxin-sensitive G protein.
The Journal of clinical investigation 1990;85(1):291-5.
1990: Jean Galitzky; Dominique Larrouy; Michel Berlan; Max Lafontan
New tools for human fat cell alpha-2A adrenoceptor characterization. Identification on membranes and on intact cells using the new antagonist [3H]RX821002.
The Journal of pharmacology and experimental therapeutics 1990;252(1):312-9.
1989: Jean Sébastien Saulnier-Blache; M Taouis; M Dauzats; A Uzan; Michel Berlan; Max Lafontan
Lipolytic action of a new alpha-2 adrenergic antagonist of the piperazinopyrimidine family: RP 55462.
The Journal of pharmacology and experimental therapeutics 1989;251(3):1187-92.
1989: Jean Sébastien Saulnier-Blache; M Taouis; M Dauzats; A Uzan; Michel Berlan; Max Lafontan
Mechanism of lipolytic action of a new alpha-2 adrenergic antagonist of the piperazinopyrimidine family: RP 55462.
The Journal of pharmacology and experimental therapeutics 1989;251(3):1193-8.
1989: Jean Sébastien Saulnier-Blache; Christian Carpéné; Dominique Langin; Max Lafontan
Imidazolinic radioligands for the identification of hamster adipocyte alpha 2-adrenoceptors.
European journal of pharmacology 1989;171(2-3):145-57.
1989: Dominique Langin; Max Lafontan; M R Stillings; Hervé Paris
[3H]RX821002: a new tool for the identification of alpha 2A-adrenoceptors.
European journal of pharmacology 1989;167(1):95-104.
1989: Jean Galitzky; Max Lafontan; Hervé Paris; Michel Berlan
Human fat cell alpha-2 adrenoceptors. II. Comparative study of partial and full agonist binding parameters using [3H]clonidine and [3H]UK-14,304.
The Journal of pharmacology and experimental therapeutics 1989;249(2):592-600.
1989: Jean Galitzky; P Mauriege; Michel Berlan; Max Lafontan
Human fat cell alpha-2 adrenoceptors. I. Functional exploration and pharmacological definition with selected alpha-2 agonists and antagonists.
The Journal of pharmacology and experimental therapeutics 1989;249(2):583-91.
1989: Philippe Valet; M Taouis; Marie-Antoinette Tran; P Montastruc; Max Lafontan; Michel Berlan
Lipomobilizing effects of procaterol and yohimbine in the conscious dog: comparison of endocrinological, metabolic and cardiovascular effects.
British journal of pharmacology 1989;97(1):229-39.
1989: Philippe Valet; Jean-Louis Montastruc; Michel Berlan; M A Tran; Max Lafontan; P Montastruc
Differential regulation of fat cell beta-2 and beta-1 adrenoceptors by endogenous catecholamines in dog.
The Journal of pharmacology and experimental therapeutics 1989;249(1):271-7.
1989: Dominique Langin; Max Lafontan
[3H]idazoxan binding at non-alpha 2-adrenoceptors in rabbit adipocyte membranes.
European journal of pharmacology 1989;159(2):199-203.
1989: François Crampes; M Marceron; M Beauville; Daniel Riviere; M Garrigues; Michel Berlan; Max Lafontan
Platelet alpha 2-adrenoceptors and adrenergic adipose tissue responsiveness after moderate hypocaloric diet in obese subjects.
International journal of obesity 1989;13(1):99-110.
1988: Jean Galitzky; M Taouis; Michel Berlan; Daniel Rivière; M Garrigues; Max Lafontan
Alpha 2-antagonist compounds and lipid mobilization: evidence for a lipid mobilizing effect of oral yohimbine in healthy male volunteers.
European journal of clinical investigation 1988;18(6):587-94.
1988: M Taouis; Michel Berlan; P Montastruc; Max Lafontan
Mechanism of the lipid-mobilizing effect of alpha-2 adrenergic antagonists in the dog.
The Journal of pharmacology and experimental therapeutics 1988;247(3):1172-80.
1988: François Crampes; M Beauville; Daniel Riviere; M Garrigues; Max Lafontan
Lack of desensitization of catecholamine-induced lipolysis in fat cells from trained and sedentary women after physical exercise.
The Journal of clinical endocrinology and metabolism 1988;67(5):1011-7.
1988: P Mauriège; G De Pergola; Michel Berlan; Max Lafontan
Human fat cell beta-adrenergic receptors: beta-agonist-dependent lipolytic responses and characterization of beta-adrenergic binding sites on human fat cell membranes with highly selective beta 1-antagonists.
Journal of lipid research 1988;29(5):587-601.
1988: Max Lafontan; Michel Berlan; M Prud'Hon
[Beta adrenergic agonists. Mechanisms of action: lipid mobilization and anabolism].
Reproduction, nutrition, development 1988;28(1):61-84.
1987: M Taouis; Michel Berlan; P Montastruc; Max Lafontan
Characterization of dog fat cell adrenoceptors: variations in alpha-2 and beta adrenergic receptors distribution according to the extent of the fat deposits and the anatomical location.
The Journal of pharmacology and experimental therapeutics 1987;242(3):1041-9.